PTIX insider filings
Protagenic Therapeutics, Inc.\new — 19 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-08-24. Screen PTIX transaction legs live →
Insider transaction summary — last 90 days
2026-08-23 to 2026-11-21, from the filings listed below: 1 insider filing (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing by 1 insider — 20,000 shares, $13,000 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 0.
- Largest priced transaction: purchase of 20,000 shares @ $0.65 ($13,000) by ARMEN GARO H, filed 2026-08-24.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| ARMEN GARO H — EXEC. CHAIR & PRINCIPAL OFF, Director | 1 | 1 leg · 20,000 sh · $13,000 | — | — |
Recent insider filings — Protagenic Therapeutics, Inc.\new
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-24 | 4 | ARMEN GARO H — EXEC. CHAIR & PRINCIPAL OFF, Director | Purchase (P): 20,000 @ $0.65 | EDGAR |
| 2026-08-20 | 4 | ARMEN GARO H — EXEC. CHAIR & PRINCIPAL OFF, Director | Purchase (P): 16,634 @ $0.59 | EDGAR |
| 2026-08-20 | 4 | ARMEN GARO H — EXEC. CHAIR & PRINCIPAL OFF, Director | Purchase (P): 2,700 @ $0.35 | EDGAR |
| 2026-08-12 | 4 | ARMEN GARO H — EXEC. CHAIR & PRINCIPAL OFF, Director | Purchase (P): 2,220 @ $0.32 | EDGAR |
| 2026-08-10 | 4 | ARMEN GARO H — EXEC. CHAIR & PRINCIPAL OFF, Director | Purchase (P): 685 @ $0.22 | EDGAR |
| 2026-08-06 | 4 | ARMEN GARO H — EXEC. CHAIR & PRINCIPAL OFF, Director | Purchase (P): 5,000 @ $0.26 | EDGAR |
| 2026-08-03 | 4 | ARMEN GARO H — EXEC. CHAIR & PRINCIPAL OFF., Director | Purchase (P): 26,291 @ $0.18 | EDGAR |
| 2024-04-01 | 4 | WRIGHT TIMOTHY R — Director | Grant/award (A): 21,250 (derivative) @ $1.74 | EDGAR |
| 2024-03-29 | 4 | Stein Robert Benjamin — Director | Grant/award (A): 75,000 (derivative) @ $1.74 | EDGAR |
| 2024-03-29 | 4 | Corvese Brian — Director | Grant/award (A): 43,750 (derivative) @ $1.74 | EDGAR |
| 2024-03-29 | 4 | Buell Jennifer — Director | Grant/award (A): 75,000 (derivative) @ $1.74 | EDGAR |
| 2024-03-29 | 4 | Barrage Khalil — Director | Grant/award (A): 22,500 (derivative) @ $1.74 | EDGAR |
| 2024-03-29 | 4 | Arrow Alexander K. — Chief Financial Officer | Grant/award (A): 100,000 (derivative) @ $1.74 | EDGAR |
| 2024-03-29 | 4 | ARMEN GARO H — Executive Chairman, Director, 10% owner | Grant/award (A): 250,000 (derivative) @ $1.74 | EDGAR |
| 2023-10-13 | 4 | Arrow Alexander K. — Chief Financial Officer | Purchase (P): 8,000 @ $0.81 | EDGAR |
| 2022-05-18 | 4 | Arrow Alexander K. — Chief Financial Officer | Purchase (P): 23,000 @ $0.71 · Purchase (P): 8,000 @ $0.72 | EDGAR |
| 2021-06-01 | 4 | Barrage Khalil — Director | Grant/award (A): 180,000 (derivative) @ $0 | EDGAR |
| 2021-05-05 | 4 | Barrage Khalil — Director | Option exercise (M): 45,000 @ $1.25 · Option exercise (M): 150,000 @ $1.25 · Option exercise (M): 45,000 @ $1.75 · Option exercise (M): 120,000 @ $1.75 · Option exercise (M): 45,000 (derivative) @ $0 · Option exercise (M): 150,000 (derivative) @ $0 · +2 more | EDGAR |
| 2021-05-03 | 4 | Arrow Alexander K. — Chief Financial Officer | Purchase (P): 1,000 @ $2.29 · Purchase (P): 1,000 @ $2.29 | EDGAR |
Recent 8-K events — Protagenic Therapeutics, Inc.\new
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-11-17 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-11-06 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-20 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-07 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-03-03 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-02-24 | 8-K | 1.01 — Entry into a Material Definitive Agreement 1.02 — Termination of a Material Definitive Agreement 2.01 — Completion of Acquisition or Disposition of Assets 3.02 — Unregistered Sales of Equity Securities 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-05 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2025-11-26 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-05 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2025-10-31 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=PTIX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs